Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications

Annals of the New York Academy of Sciences

Volumn 1007, Issue , 2003, Pages 64-78

  Stoffel Wagner, Birgit ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

17 dehydrogenase; 3 hydroxysteroid dehydrogenase; 5 reductase; Aromatase; Human brain; Neurosteroid

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; AROMATASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); GANAXOLONE; GLYCINE RECEPTOR; KAINIC ACID RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROSTEROID; NICOTINIC RECEPTOR; SEROTONIN 3 RECEPTOR; SIGMA OPIATE RECEPTOR; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE;

BIOCHEMISTRY; BIOSYNTHESIS; BRAIN REGION; CATAMENIAL EPILEPSY; CONFERENCE PAPER; DENDRITIC CELL; DEPRESSION; HUMAN; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREMENSTRUAL SYNDROME; PUERPERAL DEPRESSION; STEROIDOGENESIS; SYNAPTOGENESIS;

EID: 1342330548     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1286.007     Document Type: Conference Paper

References (101)

1. MARTINI, L. & R.C. MELCANGI. 1991. Androgen metabolism in the brain. J. Steroid Biochem. Mol. Biol. 39: 819-828.
2. LEPHART, E.D. 1993. Brain 5α-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function. Mol. Cell Neurosci. 4: 473-484.
3. NAFTOLIN, F. 1994. Brain aromatization of androgens. J. Reprod. Med. 39: 257-261.
4. ROBEL, P., M. SCHUMACHER & E.E. BAULIEU. 1999. Neurosteroids: from definition and biochemistry to physiopathologic function. In Neurosteroids. A New Regulatory Function in the Nervous System. E.E. Baulieu, P. Robel & M. Schumacher, Eds.: 1-25. Humana Press. Totowa, NJ.
5. A receptor: mechanism of action and physiological significance. Prog. Neurobiol. 38: 379-395.
6. MELLON, S. 1994. Neurosteroids: biochemistry, modes of action, and clinical relevance. J. Clin. Endocrinol. Metab. 78: 1003-1008.
7. NAFTOLIN, F., K.J. RYAN, I.J. DAVIES, et al. 1975. The formation of estrogens by central neuroendocrine tissues. Rec. Prog. Horm. Res. 31: 295-319.
8. CHUNG, B.C., K.J. MATTESON, R. VOUTILAINEN, et al. 1986. Human cholesterol side-chain cleavage enzyme, P450SCC: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc. Natl. Acad. Sci. USA 83: 8962-8966.
9. SIMPSON, E.R. & P.C. MACDONALD. 1981. Endocrine physiology of the placenta. Annu. Rev. Physiol. 43: 163-188.
10. KEENEY, D.S., Y. IKEDA, M.R. WATERMAN, et al. 1995. Cholesterol side-chain cleavage cytochrome P450 gene expression in the primitive gut of the mouse embryo does not require steroidogenic factor 1. Mol. Endocrinol. 9: 1091-1098.
11. MELLON, S. & C.F. DESCHEPPER. 1993. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629: 283-292.
12. WARNER, M. & J.-A. GUSTAFSSON. 1995. Cytochrome P450 in the brain: neuroendocrine functions. Front. Neuroendocrinol. 16: 224-236.
13. WATZKA, M., F. BIDLINGMAIER, J. SCHRAMM, et al. 1999. Sex-and age-specific differences in human brain CYP11A1 mRNA expression. J. Neuroendocrinol. 11: 901-905.
14. BEYENBURG, S., B. STOFFEL-WAGNER, M. WATZKA, et al. 1999. Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy. NeuroReport 10: 3067-3070.
15. SANNE, J.L. & K.E. KRUEGER. 1995. Expression of cytochrome P450 side-chain cleavage enzyme and 3beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J. Neurochem. 65: 528-536.
16. KOHCHI, C., K. UKENA & K. TSUTSUI. 1998. Age-and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes p450SCC, p450c17 and 3beta-HSD in the postnatal rat brain. Brain Res. 801: 233-238.
17. HU, Z.Y., E. BOURREAU, I. JUNG-TESTAS, et al. 1987. Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc. Natl. Acad. Sci. USA 84: 8215-8219.
18. CORBIN, J.C., S. GRAHAM-LORENCE, M.J. MCPHAUL, et al. 1988. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in non-steroidogenic cells. Proc. Natl. Acad. Sci. USA 85: 8948-8953.
19. HARADA, N. 1988. Cloning of a comparative cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem. Biophys. Res. Commun. 156: 725-732.
20. NAFTOLIN, F., K.J. RYAN & Z. PETRO. 1971. Aromatization of androstenedione by the diencephalon. J. Clin. Endocrinol. Metab. 33: 368-370.
21. NAFTOLIN, F., K.J. RYAN & Z. PETRO. 1971. Aromatization of androstenedione by limbic system tissue from human foetuses. J. Endocrinol. 51: 795-796.
22. DOODY, K.J. & B.R. CARR. 1989. Aromatase in human fetal tissues. Am. J. Obstet. Gynecol. 161: 1694-1697.
23. WOZNIAK, A., R.E. HUTCHINSON, C.M. MORRIS, et al. 1998. Neuroblastoma and Alzheimer's disease brain cells contain aromatase activity. Steroids 63: 263-267.
24. STOFFEL-WAGNER, B., M. WATZKA, J. SCHRAMM, et al. 1999. Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J. Steroid Biochem. Mol. Biol. 70: 237-241.
25. STOFFEL-WAGNER, B., M. WATZKA, S. STECKELBROECK, et al. 1998. Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochem. Biophys. Res. Commun. 244: 768-771.
26. STECKELBROECK, S., D. HEIDRICH, B. STOFFEL-WAGNER, et al. 1999 Characterization of aromatase cytochrome P450 activity in the human temporal lobe. J. Clin. Endocrinol. Metab. 84: 2795-2801.
27. HENDERSON, D., G. NORBISRATH & U. KERB. 1986. 1-Methyl-1,4- androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis. J. Steroid Biochem. 24: 303-306.
28. ACKERMAN, G.E., M.E. SMITH, C.R. MENDELSON, et al. 1981. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 53: 412-417.
29. ROWLANDS, M.G., J.H. DAVIES, R.J. SHEARER, et al. 1991. Comparison of aromatase activity in human prostatic, testicular and placental tissues. J. Enzyme Inhib. 4: 307-313.
30. ANDERSSON, S. & D.W. RUSSELL. 1990. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natl. Acad. Sci. USA 87: 3640-3644.
31. ANDERSSON, S., D.M. BERMAN, E.P. JENKINS, et al. 1991. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354: 159-161.
32. MARTINI, L. 1982. The 5α-reduction of testosterone in the neuroendocrine structures: biochemical and physiological implications. Endocr. Rev. 3: 1-25.
33. LI, X., P.J. BERTICS & H.J. KARAVOLAS. 1997. Regional distribution of cytosolic and particulate α-dihydroprogesterone 3α- hydroxysteroid oxidoreductases in female rat brain. J. Steroid Biochem. Mol. Biol. 60: 311-318.
34. SAITOH, H., K. HIRATO, T. YANAIHARA, et al. 1982. A study of 5α-reductase in human fetal brain. Endocrinol. Jpn. 29: 461-467.
35. SCHINDLER, A.E. 1976. Steroid metabolism in foetal tissues. IV. Conversion of testosterone to 5α-dihydrotestosterone in human foetal brain. J. Steroid Biochem. 7: 97-100.
36. MICKAN, H. 1972. Metabolism of 4-14C-progesterone and 4-14-C-testosterone in brain of the previable human fetus. Steroids 19: 659-668.
37. JENKINS, J.S. & C.J. HALL. 1977. Metabolism of [14C]testosterone by human foetal and adult brain tissue. J. Endocrinol. 74: 425-429.
38. CELOTTI, F., R.C. MELCANGI, P. NEGRI-CESI, et al. 1986. A comparative study of the metabolism of testosterone in the neuroendocrine structures of several animal species. Neuroendocrinol. Lett. 5: 227-236.
39. STOFFEL-WAGNER, B., M. WATZKA, S. STECKELBROECK, et al. 1998. Expression of 5α-reductase in the human temporal lobe of children and adults. J. Clin. Endocrinol. Metab. 83: 3636-3642.
40. STOFFEL-WAGNER, B., S. BEYENBURG, M. WATZKA, et al. 2000. Expression of 5α-reductase and 3α-hydroxisteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia 41: 140-147.
41. THIGPEN, A.E., R.I. SILVER, J.M. GUILEYARDO, et al. 1993. Tissue distribution and ontogeny of steroid 5α-reductase isoenzyme expression. J. Clin. Invest. 92: 903-910.
42. NORMINGTON, K. & D.W. RUSSELL. 1992. Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. J. Biol. Chem. 267: 19548-19554.
43. STECKELBROECK, S., M. WATZKA, R. REICHELT, et al. 2001. Characterization of the 5α-reductase-3α-hydroxysteroid dehydrogenase complex in the human brain. J. Clin. Endocrinol. Metab. 86: 1324-1331.
44. MASSA, R., S. JUSTO & L. MARTINI. 1975. Conversion of testosterone into 5a-reduced metabolites in the anterior pituitary and in the brain of maturing rats. J. Steroid Biochem. 19: 235-239.
45. SELMANOFF, M.K., L.D. BRODKIN, R.I. WEINER, et al. 1977. Aromatization and 5α-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology 101: 841-848.
46. QIN, K.N., M.I. NEW & K.C. CHENG. 1993. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3α-hydroxysteroid dehydrogenase. J Steroid Biochem. Mol. Biol. 52: 141-147.
47. KHANNA, M., K.-N. QIN, R.W. WANG, et al. 1995. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxisteroid dehydrogenases. J. Biol. Chem. 270: 20162-20168.
48. KHANNA, M., K.N. QIN & K.-C. CHENG. 1995. Distribution of 3alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans. J. Steroid Biochem. Mol. Biol. 53: 41-46.
49. PENNING, T.M. 1997. Molecular endocrinology of hydroxisteroid dehydrogenases. Endocr. Rev. 18: 281-305.
50. PENNING, T.M., M.E. BURCZYNSKI, J.M. JEZ, et al. 2000. Human 3α-hydroxisteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351: 61-77.
51. PELTOKETO, H., V. LUU-THE & J. SIMARD. 1999 17β-hydroxisteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) familiy; nomenclature and main characteristics of the 17HSD/KSR enzymes. J. Mol. Endocrinol. 23: 1-11.
52. KRAZEISEN, A., R. BREITLING, K. IMAI, et al. 1999. Determination of cDNA, gene structure and chromosomal localization of the novel 17β- hyxdroxysteroid dehydrogenase type 7. FEBS Lett. 460: 373-379.
53. LABRIE, F., V. LUU-THE, S.X. LIN, et al. 1997. A key role of 17β-hydroxisteroid dehydrogenases in sex steroid biology. Steroids 62: 148-158.
54. MARTEL, C., M.H. MELNER, D. GAGNÉ, et al. 1994. Widespread tissue distribution of steroid sulfatase, 3β-hydroxisteroid dehydrogenase/D5-D4 isomerase (3β-HSD), 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey. Mol. Cell. Endocrinol. 104: 103-111.
55. JAFFE, R.B. 1969. Testosterone metabolism in target tissues: hypothalamic and pituitary tissues of the adult rat and human fetus, and the immature rat epiphysis. Steroids 14: 483-498.
56. MILEWICH, L., B.R. CARR & R.A. FRENKEL. 1990. 17β- hydroxysteroid oxidoreductases of human fetal and adult tissues: immunological cross-reactivity with an anti-human placental cytosolic 17β-hydroxysteroid oxidoreductase antibody. Placenta 11: 95-108.
57. STOFFEL-WAGNER, B., M. WATZKA, S. STECKELBROECK, et al. 1999. D. Expression of 17β-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J. Endocrinol. 160: 119-126.
58. STECKELBROECK, S., M. WATZKA, B. STOFFEL-WAGNER, et al. 2001. Expression of 17β-hydroxysteroid dehydrogenase type 5 mRNA in the human brain. Mol. Cell. Endocrinol. 171: 165-168.
59. STECKELBROECK, S., B. STOFFEL-WAGNER, R. REICHELT, et al. 1999. Characterization of 17β-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe. J. Neuroendocrinol. 11: 457-464.
60. IWAHASHI, K., Y. KAWAI, H. SUWAKI, et al. 1993. A localization study of the cytochrome P-450(21)-linked monooxygenase system in adult rat brain. J. Steroid Biochem. Mol. Biol. 44: 163-169.
61. STROMSTEDT, M. & M.R. WATERMAN. 1995. Messenger mRNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Res. Mol. Brain Res. 34: 75-88.
62. MELLON, S.H. & W.L. MILLER. 1989. Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J. Clin. Invest. 84: 1497-1502.
63. BEYENBURG, S., M. WATZKA, H. CLUSMANN, et al. 2001. Messenger RNA of steroid 21-hydroxylase (CYP21) is expressed in the human hippocampus. Neurosci. Lett. 308: 111-114.
64. DUPONT, E., J. SIMARD, V. LUU-THE, et al. 1994. Localization of 3beta-hydroxysteroid dehydrogenase in rat brain as studied by in situ hybridization. Mol. Cell. Neurosci. 5: 119-123.
65. GUENNOUN, R., R.J. FIDDES, M. GOUÉZOU, et al. 1995. A key enzyme in the biosynthesis of neurosteroids, 3β-hydroxysteroid dehydrogenase/D5-D4-isomerase (3β-HSD), is expressed in rat brain. Mol. Brain Res. 30: 287-300.
66. GOMEZ-SANCHEZ, C.E., M.Y. ZHOU, E.N. COZZA, et al. 1996. Corticoid synthesis in the central nervous system. Endocr. Res. 22: 463-470.
67. ERDMANN, B., H. GERST, A. LIPPOLDT, et al. 1996. Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats. Brain Res. 733: 73-82.
68. GOMEZ-SANCHEZ, C.E., M.Y. ZHOU & E.N. COZZA. 1997. Aldosterone biosynthesis in the rat brain. Endocrinology 138: 3369-3373.
69. BAULIEU, E.E. & P. ROBEL. 1990. Neurosteroids: a new brain function? J. Steroid Biochem. Mol. Biol. 37: 395-403.
70. COMPAGNONE, N.A., A. BUFONE & J.L.R. RUBENSTEIN. 1995. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136: 5212-5223.
71. PAUL, S.M. & R.H. PURDY. 1992. Neuroactive steroids. FASEB J. 6: 2311-2322.
72. BAULIEU, E.E. 1997. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Rec. Prog. Horm. Res. 52: 1-33.
73. BAULIEU, E.E. 1998. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23: 963-987.
74. MENSAH-NYAGAN, A., J.L. DO-REGO, D. BEAUJEAN, et al. 1999. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51: 63-81.
75. RUPPRECHT, R. & F. HOLSBOER. 1999. Neuroactive steroids: mechanism of action and neuropsychopharmacological perspectives. Trends Neurosci. 22: 410-416.
76. WU, F.S., T.T. GIBBS & D.H. FARB. 1991. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40: 333-336.
77. PRINCE, R.J. & M.A. SIMMONDS. 1992. Steroid modulation of the strychnine-sensitive glycine receptor. Neuropharmacology. 31: 201-205.
78. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. USA 92: 3774-3778.
79. LAMBERT, J.J., D. BELELLI, C. HILL-VENNING, et al. 1995. Neurosteroids and GABA-A receptor function. Trends Pharmacol. Sci. 16: 295-303.
80. SELYE, H. 1941. The anesthetic effect of steroid hormones. Proc. Soc. Exp. Biol. Med. 46: 116-121.
81. RICHARDS, C.D. & T.R. HESKETH. 1975. Implications for theories of anaesthesia of antagonism between anaesthetic and non-anaesthetic steroids. Nature 256: 179-182.
82. BÄCKSTRÖM, T. 1976. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54: 321-347.
83. BÄCKSTRÖM, T. 1975. Epilepsy in women: oestrogen and progesterone plasma levels. Experientia 32: 248-249.
84. KOKATE, T.G., B.E. SVENSSON & M.A. ROGAWSKI. 1994. Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Therap. 270: 1223-1229.
85. BELELLI, D., N.C. LAN & K.W. GEE. 1990. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14: 315-322.
86. MONAGHAN, E.P., L.A. NAVALTA, L. SHUM, et al. 1997. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity. Epilepsia 38: 1026-1031.
87. MONAGHAN, E.P., S. HARRIS, D. BLUM, et al. 1997. Ganaxolone in the treatment of complex partial seizures: a double-blind presurgical design. Epilepsia (Suppl. 8) 38: S179.
88. SHIELDS, W.D., J.F. KERRIGAN, D.L. BLUESTONE, et al. 1997. Ganaxolone in the treatment of refractory infantile spasms. Ann. Neurol. 42: 503-504.
89. STRÖHLE, A., E. ROMEO, B. HERMANN, et al. 1999. Concentrations of 3alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychol. 45: 274-277.
90. BIEDERMANN, K. & P. SCHOCH. 1995. Do neuroactive steroids cause fatigue in pregnancy? Eur. J. Obstet. Gynecol. Reprod. Biol. 58: 15-18.
91. RUPPRECHT, R. 1997. The neuropsychopharmacological potential of neuroactive steroids. J. Psych. Res. 31: 297-314.
92. WANG, M., L. SEIPPEL, R.H. PURDY, et al. 1996. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J. Clin. Endocrinol. Metab.. 81: 1076-1082.
93. ORENTREICH, N., J.L. BRIND, J.H. VOGELMAN, et al. 1992. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75: 1002-1004.
94. GOODYER, I.M., J. HERBERT, P.M. ALTHAM, et al. 1996. Adrenal secretion during major depression in 8-to 16-year olds. I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 26: 245-256.
95. KIMONIDES, V.G., N.H. KHATIBI, C.N. SVENDSEN, et al. 1998 Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 95: 1852-1857.
96. NÄSMAN, B., B. OLSSON, T. BÄCKSTRÖM, et al. 1991. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multiinfarct dementia. Biol. Psychiatry 30: 684-690.
97. MAGRI, F., F. TERENZI, T. RICCIARDI, et al. 2000. Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia. Dement. Geriatr. Cogn. Disord. 11: 90-99.
98. HILLEN, T., A. LUN, F.M. REISCHIES, et al. 2000. DHEA-S plasma levels and incidence of Alzheimer's disease. Biol. Psychiatry 47: 161-163.
99. WOLF, O.T., O. NEUMANN, D.H. HELLHAMMER, et al. 1997. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82: 2363-2367.
100. WOLF, O.T., E. NAUMANN, D.H. HELLHAMMER, et al. 1998. Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory and well-being. J. Gerontol. A Biol. Sci. Med. Sci. 53: M385-M390.
101. HUPPERT, F.A., J.K. VAN NIERERK & J. HERBERT. 2000. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being. Cochrane Database Syst. Rev. 2: CD000304.